StonvexLoading…
StonvexStonvexStonvexCore line items from NGS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $15.01M | $10.36M | $8.80M | $7.23M |
Operating Income | $10.46M | $431.00K | $-12.41M | $-3.60M |
Net Income | $4.75M | $-569.00K | $-9.18M | $1.81M |
EPS (Diluted) | $0.38 | $-0.05 | $-0.70 | $0.14 |
Total Assets | $478.73M | $328.25M | $298.51M | $306.80M |
Total Liabilities | $242.84M | $98.17M | $62.60M | $55.26M |
Cash & Equivalents | $2.75M | $3.37M | $22.94M | $28.93M |
Free Cash Flow OCF − CapEx | $-135.91M | $-37.36M | $2.82M | $17.39M |
Shares Outstanding | 12.40M | 13.52M | 13.39M | 13.30M |